Evolus, Inc. EOLS
NASDAQ · United States · Health Technology
$7.77-0.23 (-2.88%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 0.01 | -0.03 | +122.3% | $84.08M | +3.1% | +21.1%$6.12→$7.41 |
| Q1 2026 | 2026-05-04 | -0.05 | -0.12 | +58.3% | — | — | +19.5% |
| Q4 2025 | 2026-03-03 | 0.01 | 0.04 | -75.0% | — | — | +30.3%$4.29→$5.59 |
| Q3 2025 | 2025-11-05 | -0.20 | -0.26 | +23.1% | — | — | +12.0%$6.41→$7.18 |
| Q4 2024 | 2025-03-04 | 0.01 | 0.02 | -50.0% | — | — | — |
| Q4 2023 | 2024-03-07 | -0.14 | -0.07 | -100.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.